# Innate Pharma SA: Form 6-K, filed Jan 4, 2022

- Company: [Innate Pharma SA](/companies/ipha.md) (CIK 1598599)
- Form: 6-K
- Filed: 2022-01-04
- Accepted by EDGAR: Jan 4, 2022, 06:02 ET
- Period: 2022-01-04
- Accession: 0001157523-22-000004
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1598599/000115752322000004/a52556916.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1598599/000115752322000004/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1598599/000115752322000004/a52556916.htm

Filed Jan 4, 2022.
Source: SEC EDGAR, the filing index for accession 0001157523-22-000004. Last ingested by Listed: Nov 12, 2026, 17:11 ET. No prices; not investment advice.